Fast‐acting insulin aspart in people with type 2 diabetes: Earlier onset and greater initial exposure and glucose‐lowering effect compared with insulin aspart

AIMS: To investigate the pharmacokinetic/pharmacodynamic properties of fast‐acting insulin aspart (faster aspart) versus insulin aspart (IAsp) in people with type 2 diabetes (T2D). MATERIALS AND METHODS: In a randomized, double‐blind, crossover design, 61 people with T2D usually treated with insulin...

Descripción completa

Detalles Bibliográficos
Autores principales: Pieber, Thomas R., Svehlikova, Eva, Brunner, Martina, Halberg, Inge B., Due Thomsen, Karen Margrete, Haahr, Hanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771872/
https://www.ncbi.nlm.nih.gov/pubmed/31069935
http://dx.doi.org/10.1111/dom.13767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771872/
https://www.ncbi.nlm.nih.gov/pubmed/31069935
http://dx.doi.org/10.1111/dom.13767

Ejemplares similares